Variant report
Variant | nsv525327 |
---|---|
Chromosome Location | chr15:55139422-55160395 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2899565 | chr15:55139422-55139423 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs148384944 | chr15:55139424-55139425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143310357 | chr15:55139438-55139439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111301660 | chr15:55139440-55139441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147101136 | chr15:55139482-55139483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557903688 | chr15:55139484-55139485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs577872451 | chr15:55139487-55139488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs117823145 | chr15:55139502-55139503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560165304 | chr15:55139505-55139506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78461184 | chr15:55139506-55139507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76642628 | chr15:55139532-55139533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs143952786 | chr15:55139538-55139539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs2414383 | chr15:55139544-55139545 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs551699092 | chr15:55139549-55139550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2414384 | chr15:55139568-55139569 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs60078031 | chr15:55139571-55139572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147276910 | chr15:55139577-55139578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560049520 | chr15:55139634-55139635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567857164 | chr15:55139661-55139662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139749302 | chr15:55139674-55139675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113794176 | chr15:55139688-55139689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190631166 | chr15:55139726-55139727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs77369973 | chr15:55139735-55139736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2414385 | chr15:55139748-55139749 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs5812784 | chr15:55139772-55139773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558764144 | chr15:55139781-55139782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577795917 | chr15:55139795-55139796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527675722 | chr15:55139838-55139839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149358112 | chr15:55139840-55139841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554075993 | chr15:55139854-55139855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183021955 | chr15:55139880-55139881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2414386 | chr15:55139887-55139888 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs10518788 | chr15:55139904-55139905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574578880 | chr15:55139912-55139913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77072290 | chr15:55139923-55139924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs76669094 | chr15:55139931-55139932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564828339 | chr15:55139963-55139964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12905779 | chr15:55139964-55139965 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs28363909 | chr15:55139971-55139972 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs561569030 | chr15:55139992-55139993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377248294 | chr15:55141207-55141208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1879332 | chr15:55141265-55141266 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs533607224 | chr15:55141271-55141272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs28625070 | chr15:55141292-55141293 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs189878772 | chr15:55141306-55141307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546209746 | chr15:55141308-55141309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1879333 | chr15:55141309-55141310 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs10468011 | chr15:55141329-55141330 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs180824550 | chr15:55141406-55141407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1879334 | chr15:55141411-55141412 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 22032731 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cancer | 21129771 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 17440070 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:55139400-55139800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
2 | chr15:55139400-55139800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr15:55139600-55140000 | Enhancers | Primary hematopoietic stem cells | blood |
4 | chr15:55141200-55141400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr15:55141400-55142400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr15:55142400-55142600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr15:55142400-55143200 | Enhancers | Gastric | stomach |
8 | chr15:55155200-55155800 | Enhancers | Fetal Muscle Trunk | muscle |
9 | chr15:55160200-55160400 | Active TSS | Small Intestine | intestine |